AlphaFold predicted structure
SLC6A5 · Q9Y345

Mean pLDDT
73.4/ 100
Confident
797 residues
Confidence breakdown
- Very high(≥ 90)41%
- Confident(70–90)26%
- Low(50–70)7%
- Very low(< 50)26%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
solute carrier family 6 member 5
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Brain channelopathy
BOTH monoallelic and biallelic, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalParoxysmal central nervous system disorders
BOTH monoallelic and biallelic, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
BOTH monoallelic and biallelic, autosomal or pseudoautosomalLikely inborn error of metabolism
BOTH monoallelic and biallelic, autosomal or pseudoautosomalAdult onset dystonia, chorea or related movement disorder
BOTH monoallelic and biallelic, autosomal or pseudoautosomalAdult onset neurodegenerative disorder
BOTH monoallelic and biallelic, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BOTH monoallelic and biallelic, autosomal or pseudoautosomal+3 more panels — install the extension to see the full list inline on any page.
hereditary hyperekplexia
hyperekplexia 3
hyperekplexia
Exaggerated startle response
hereditary disease
brain disorder
cervicitis
placenta praevia
spondylolisthesis
DNA methylation
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Sodium- and chloride-dependent glycine transporter 2
Sodium- and chloride-dependent glycine transporter (PubMed:10381548, PubMed:10606742, PubMed:16751771, PubMed:31370103, PubMed:9845349). Terminates the action of glycine by its high affinity sodium-dependent reuptake into presynaptic terminals (PubMed:9845349). May be responsible for the termination of neurotransmission at strychnine-sensitive glycinergic synapses (PubMed:9845349)
SLC6A5 · Q9Y345

Mean pLDDT
73.4/ 100
Confident
797 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0